Human IL-17D Antibody, R&D Systems™

IL-17D

Monoclonal

LYOPH

Western Blot 1 ug/mL, Immunohistochemistry 8-25 ug/mL, Intracellular Staining by Flow Cytometry 2.5 ug/10^6 cells, CyTOF-ready

Q8TAD2.1

IL17D

E. coli-derived recombinant human IL-17D Ala18-Pro202 Accession # Q8TAD2.1

100 μg

Primary

Detects human IL-17D in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human (rh) IL-17, rhIL-17B, rhIL-17C, rhIL-17E, or rhIL-17F is observed.

Human

Purified

Western Blot, Immunohistochemistry, Flow Cytometry, CyTOF

246018

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

FLJ30846, IL17D, IL-17Dinterleukin 27, IL-22, IL-27interleukin-17D, IL27interleukin-27, interleukin 17D, Interleukin-27

Mouse

Protein A or G purified from hybridoma culture supernatant

RUO

53342

Reconstitute at 0.5 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

IgG2b